Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Antiparkinson medication"'
Autor:
Michael P. Trevarrow, Miranda J. Munoz, Yessenia M. Rivera, Rishabh Arora, Quentin H. Drane, Gian D. Pal, Leonard Verhagen Metman, Lisa C. Goelz, Daniel M. Corcos, Fabian J. David
Publikováno v:
Physiological Reports, Vol 12, Iss 17, Pp n/a-n/a (2024)
Abstract The motor impairments experienced by people with Parkinson's disease (PD) are exacerbated during memory‐guided movements. Despite this, the effect of antiparkinson medication on memory‐guided movements has not been elucidated. We evaluat
Externí odkaz:
https://doaj.org/article/5927c8ff3ac64e1ca8f1c1bb4643c685
Autor:
Miranda J. Munoz, Rishabh Arora, Yessenia M. Rivera, Quentin H. Drane, Gian D. Pal, Leo Verhagen Metman, Sepehr B. Sani, Joshua M. Rosenow, Lisa C. Goelz, Daniel M. Corcos, Fabian J. David
Publikováno v:
Frontiers in Human Neuroscience, Vol 17 (2023)
BackgroundAntiparkinson medication and subthalamic nucleus deep brain stimulation (STN-DBS), two common treatments of Parkinson’s disease (PD), effectively improve skeletomotor movements. However, evidence suggests that these treatments may have di
Externí odkaz:
https://doaj.org/article/a81a000774d54beeaf61f15af1ceb6b5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anita Valmarska
Publikováno v:
ICHI
Computer-assisted management of patients’ treatment is a challenge, especially for chronic diseases where patients are exposed to treatments with multiple medications. While the exposure to prescribed medications aims at reducing the severity of sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d677e33e006750d8f1a785aff91c002
https://doi.org/10.1109/ichi48887.2020.9374329
https://doi.org/10.1109/ichi48887.2020.9374329
Autor:
Mats Nilsson, Örjan Skogar
Publikováno v:
Journal of Multidisciplinary Healthcare
Orjan Skogar,1,2 Mats Nilsson1,3 1FUTURUM, Academy for Health and Care, Region Jönköping County, Jönköping, Sweden; 2Institution of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden; 3Department of Medical and Healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de913c2545d50351b6618599ed628ee5
https://doi.org/10.2147/jmdh.s170307
https://doi.org/10.2147/jmdh.s170307
Autor:
Nicholas W. Sterling, Guodong Liu, Douglas L. Leslie, Honglei Chen, Xuemei Huang, Lan Kong, Richard B. Mailman, Mechelle M. Lewis
Publikováno v:
Movement Disorders. 32:913-917
Objective Using a large U.S. claims database (MarketScan), we investigated the controversy surrounding the role of statins in Parkinson's disease (PD). Methods We performed a retrospective case-control analysis. First, we identified 2322 incident PD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7c97733ec05f8ca703fa46401f37db8
https://doi.org/10.1002/mds.27006
https://doi.org/10.1002/mds.27006
Publikováno v:
Clinical Neurophysiology. 128:e369-e371
Background In 2014 a complex neurological syndrome with parasomnia, sleep breathing dysfunction and variable bulbar symptoms associated with antibodies to IgLON5, a neuronal cell-adhesion protein, was described (Sabater et al., 2016). Postmortal stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::768a135a64e97c020823dd7598edba9b
https://doi.org/10.1016/j.clinph.2017.06.159
https://doi.org/10.1016/j.clinph.2017.06.159
Autor:
Jack J. Chen
Publikováno v:
The Mental Health Clinician
Persistent psychotic symptoms will develop in up to 60% of patients with Parkinson disease (PD). The initial approach to the management of PD psychosis (PDP) begins with addressing concurrent systemic conditions associated with psychotic behavior, su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41915d8ebf065310f89ca494847f1119
https://pubmed.ncbi.nlm.nih.gov/29955532
https://pubmed.ncbi.nlm.nih.gov/29955532
Publikováno v:
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 45(4)
Objective: This study aimed to systematically review the effects of currently prescribed antiparkinson medication on cognition in patients with mild-to-moderate Parkinson’s disease (PD) who were either cognitively intact or mildly impaired. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::312ab5a54ed9410f2d1073e9bd8e0999
https://pubmed.ncbi.nlm.nih.gov/29747716
https://pubmed.ncbi.nlm.nih.gov/29747716